Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MELANOMA"" wg kryterium: Temat


Tytuł :
Oral exposure to BDE-209 modulates metastatic spread of melanoma in C57BL/6 mice inoculated with B16-F10 cells.
Autorzy :
Brito PM; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
Biscaia SMP; Laboratório de Investigações de Polissacarídeos Sulfatados, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
de Souza TL; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
Ramos AB; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
Leão-Buchir J; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
de Almeida Roque A; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
de Lima Bellan D; Laboratório de Investigações de Polissacarídeos Sulfatados, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
da Silva Trindade E; Laboratório de Investigações de Polissacarídeos Sulfatados, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
Filipak Neto F; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil.
de Oliveira Ribeiro CA; Laboratório de Toxicologia Celular, Departamento de Biologia Celular, Universidade Federal Do Paraná, CEP 81.531-980, Curitiba, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Chemosphere [Chemosphere] 2020 Dec; Vol. 260, pp. 127556. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article
MeSH Terms :
Mice, Inbred C57BL*
Halogenated Diphenyl Ethers/*pharmacology
Melanoma/*pathology
Neoplasm Metastasis/*pathology
Alanine Transaminase/blood ; Animals ; Aspartate Aminotransferases/blood ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Female ; Flame Retardants/pharmacology ; Halogenated Diphenyl Ethers/toxicity ; Heterografts ; Humans ; Liver/drug effects ; Liver/pathology ; Melanoma, Experimental ; Mice
Czasopismo naukowe
Tytuł :
[A case of meningeal melanomatosis diagnosed by immunostaining of cerebrospinal fluid].
Autorzy :
Tamura Y; Department of Neurology, Nagaoka Red Cross Hospital.
Umeda Y; Department of Neurology, Nagaoka Red Cross Hospital.
Umeda M; Department of Neurology, Nagaoka Red Cross Hospital.
Oyake M; Department of Neurology, Nagaoka Red Cross Hospital.
Usuda H; Department of Pathology, Nagaoka Red Cross Hospital.
Fujita N; Department of Neurology, Nagaoka Red Cross Hospital.
Pokaż więcej
Źródło :
Rinsho shinkeigaku = Clinical neurology [Rinsho Shinkeigaku] 2020 Aug 07; Vol. 60 (8), pp. 565-568. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Cerebrospinal Fluid*
Biomarkers, Tumor/*cerebrospinal fluid
Cytodiagnosis/*methods
Melanoma/*cerebrospinal fluid
Melanoma/*diagnosis
Meningeal Carcinomatosis/*cerebrospinal fluid
Meningeal Carcinomatosis/*diagnosis
Meningeal Neoplasms/*cerebrospinal fluid
Meningeal Neoplasms/*diagnosis
Staining and Labeling/*methods
Aged ; Female ; Humans ; Melanoma-Specific Antigens/cerebrospinal fluid ; Neoplasms, Unknown Primary ; S100 Proteins/cerebrospinal fluid
Czasopismo naukowe
Tytuł :
Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Autorzy :
Han S; Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, P. R. China. , Chinese Academy of Sciences, Beijing 100190, P.R. China. .
Wang W; Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, P. R. China. .
Wang S; Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, P. R. China. .
Wang S; Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P.R. China. .
Ju R; Beijing Institute of Petrochemical Technology, Beijing 102617, P.R. China.
Pan Z; Beijing Institute of Petrochemical Technology, Beijing 102617, P.R. China.
Yang T; Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P.R. China. .
Zhang G; Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P.R. China. .
Wang H; Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University, Harbin 150040, P. R. China. .
Wang L; Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P.R. China. .
Pokaż więcej
Źródło :
Nanoscale [Nanoscale] 2019 Nov 14; Vol. 11 (42), pp. 20206-20220. Date of Electronic Publication: 2019 Oct 17.
Typ publikacji :
Journal Article
MeSH Terms :
Biomimetic Materials*/chemistry
Biomimetic Materials*/pharmacology
Flavonoids*/chemistry
Flavonoids*/pharmacology
Macrophages*/immunology
Macrophages*/pathology
Melanoma, Experimental*/immunology
Melanoma, Experimental*/pathology
Melanoma, Experimental*/therapy
Immunity, Cellular/*drug effects
Nanoparticles/*chemistry
Animals ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Female ; Melanoma-Specific Antigens/chemistry ; Melanoma-Specific Antigens/pharmacology ; Mice ; Oligodeoxyribonucleotides/chemistry ; Oligodeoxyribonucleotides/pharmacology ; Peptides/chemistry ; Peptides/pharmacology ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-Tumor M1 Macrophages.
Autorzy :
Park SM; Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea.
Do-Thi VA; Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea.
Lee JO; Department of Life Sciences, POSTECH, Pohang 37673, Korea.
Lee H; Institute of Biotechnology, Chungnam National University, Daejeon 34134, Korea.
Kim YS; Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea.
Pokaż więcej
Źródło :
Molecules and cells [Mol Cells] 2020 May 31; Vol. 43 (5), pp. 479-490.
Typ publikacji :
Journal Article
MeSH Terms :
Interleukin-9/*metabolism
Lung Neoplasms/*immunology
Macrophages/*immunology
Melanoma/*immunology
Neoplasms, Experimental/*immunology
Animals ; Cytokines/metabolism ; Female ; Humans ; Lung Neoplasms/secondary ; Lung Neoplasms/therapy ; Macrophage Activation ; Melanoma/pathology ; Melanoma, Experimental ; Mice ; Mice, Inbred C57BL ; Neoplasm Metastasis ; Neoplasms, Experimental/pathology ; Th1 Cells/immunology
Czasopismo naukowe
Tytuł :
Importance of PET/CT examination in patients with malignant uveal melanoma.
Autorzy :
Marko M
Leško P
Jurenová D
Furda R
Greguš M
Pokaż więcej
Transliterated Title :
Význam PET/CT vyšetrenia u pacientov s malígnym melanómom uvey.
Źródło :
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti [Cesk Slov Oftalmol] 2020 Winter; Vol. 76 (1), pp. 37-44.
Typ publikacji :
Journal Article
MeSH Terms :
Melanoma*/diagnostic imaging
Melanoma*/surgery
Radiosurgery*
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography ; Tomography, X-Ray Computed ; Uveal Neoplasms
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation.
Autorzy :
Teshima Y; Re-Examination, Patient Safety Japan Re-Examination, Regulatory Office Japan, Novartis Pharma K.K., Toranomon Hills Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan. .
Kizaki M; PVO Japan, Patient Safety Japan, Regulatory Office Japan, Novartis Pharma K.K., Toranomon Hills Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan.
Kurihara R; Biostatistics, Clinical Development, Novartis Pharma K.K., Toranomon Hills Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan.
Kano R; Solid Tumor Medical Franchise Department, Oncology Medical Affairs Department, Novartis Pharma K.K., Toranomon Hills Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan.
Harumiya M; Clinical Development of Solid Tumor Oncology Group, Clinical Development Department, Novartis Pharma K.K., Toranomon Hills Mori Tower, 1-23-1, Toranomon, Minato-ku, Tokyo, 105-6333, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Oct; Vol. 25 (10), pp. 1870-1878. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Melanoma/*drug therapy
Melanoma/*genetics
Proto-Oncogene Proteins B-raf/*genetics
Adult ; Aged ; Aged, 80 and over ; Asian Continental Ancestry Group ; Female ; Fever/chemically induced ; Humans ; Imidazoles/administration & dosage ; Male ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Mutation ; Oximes/administration & dosage ; Pregnancy ; Progression-Free Survival ; Pyridones/administration & dosage ; Pyrimidinones/administration & dosage ; Surveys and Questionnaires ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal.
Autorzy :
Baumann T; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Dunkel A; Leibniz-Institute of Food Systems Biology, TUM, Munich, Germany.
Schmid C; Food Chemistry and Molecular Sensory Science, TUM, Munich, Germany.
Schmitt S; Institute for Toxicology and Environmental Hygiene, School of Medicine, TUM, Munich, Germany.
Hiltensperger M; Department of Experimental Neuroimmunology, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Lohr K; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Laketa V; Department of Infectious Diseases, German Center for Infection Research, Heidelberg University, Heidelberg, Germany.
Donakonda S; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Ahting U; Institute of Human Genetics, Stoffwechselzentrum, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Lorenz-Depiereux B; Institute of Human Genetics, Helmholtz Zentrum München, Munich, Germany.
Heil JE; Carl Zeiss Microscopy, Göttingen, Germany.
Schredelseker J; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Simeoni L; Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany.
Fecher C; Institute of Neuronal Cell Biology, TUM, Munich Cluster for Systems Neurology and German Center for Neurodegenerative Diseases, Munich, Germany.
Körber N; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.
Bauer T; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.
Hüser N; Department of Surgery, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Hartmann D; Department of Surgery, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Laschinger M; Department of Surgery, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Eyerich K; Department of Dermatology and Allergy, TUM, Munich, Germany.
Eyerich S; Center of Allergy and Environment, TUM and Helmholtz Zentrum München, Munich, Germany.
Anton M; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Streeter M; Department of Chemistry, Yale University, New Haven, CT, USA.
Wang T; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Schraven B; Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany.
Spiegel D; Department of Chemistry, Yale University, New Haven, CT, USA.; Department of Pharmacology, Yale University, New Haven, CT, USA.
Assaad F; Research Department Plant Sciences, Center for Life Science, TUM, Munich, Germany.
Misgeld T; Institute of Neuronal Cell Biology, TUM, Munich Cluster for Systems Neurology and German Center for Neurodegenerative Diseases, Munich, Germany.
Zischka H; Institute for Toxicology and Environmental Hygiene, School of Medicine, TUM, Munich, Germany.; Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Neuherberg, Germany.
Murray PJ; Max Planck Institute of Biochemistry, Munich, Germany.
Heine A; Medical Clinic III for Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Immunology, University Bonn, Bonn, Germany.
Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany.
Korn T; Department of Experimental Neuroimmunology, Klinikum Rechts der Isar, School of Medicine, TUM, Munich, Germany.
Dawid C; Food Chemistry and Molecular Sensory Science, TUM, Munich, Germany.
Hofmann T; Leibniz-Institute of Food Systems Biology, TUM, Munich, Germany.; Food Chemistry and Molecular Sensory Science, TUM, Munich, Germany.
Knolle PA; Institute of Molecular Immunology and Experimental Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany. .; Institute of Molecular Immunology, School of Life Sciences, TUM, Munich, Germany. .; German Center for Infection Research, Munich, Germany. .
Höchst B; Institute of Molecular Immunology, School of Life Sciences, TUM, Munich, Germany. .
Pokaż więcej
Źródło :
Nature immunology [Nat Immunol] 2020 May; Vol. 21 (5), pp. 555-566. Date of Electronic Publication: 2020 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Immunotherapy/*methods
Melanoma/*immunology
Myeloid-Derived Suppressor Cells/*immunology
Pyruvaldehyde/*metabolism
Amine Oxidase (Copper-Containing)/metabolism ; Animals ; CD8-Positive T-Lymphocytes/transplantation ; Cell Communication ; Cell Proliferation ; Humans ; Immune Tolerance ; Lymphocyte Activation ; Melanoma, Experimental ; Mice ; Mice, Transgenic ; Neoplasms, Experimental ; Programmed Cell Death 1 Receptor/metabolism
Czasopismo naukowe
Tytuł :
Organogold drug Auranofin exhibits anti-melanogenic activity in B16F10 and MNT-1 melanoma cells.
Autorzy :
Goenka S; Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794-5281, USA. .
Simon SR; Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794-5281, USA.; Department of Pathology, Stony Brook University, Stony Brook, NY, USA.; Department of Biochemistry and Cellular Biology, Stony Brook University, Stony Brook, NY, USA.
Pokaż więcej
Źródło :
Archives of dermatological research [Arch Dermatol Res] 2020 Apr; Vol. 312 (3), pp. 213-221. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Journal Article
MeSH Terms :
Auranofin/*therapeutic use
Hyperpigmentation/*drug therapy
Melanins/*metabolism
Melanoma/*drug therapy
Skin Neoplasms/*drug therapy
Animals ; Drug Repositioning ; Humans ; Melanoma, Experimental ; Mice ; Monophenol Monooxygenase/metabolism ; Rheumatic Diseases/drug therapy ; Signal Transduction ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Enucleation after Stereotactic Radiosurgery in Patients with Uveal Melanoma.
Autorzy :
Zahorjanová P
Sekáč J
Babál P
Štubňa M
Pokaż więcej
Transliterated Title :
ENUKLEÁCIA PO STEREOTAKTICKEJ RÁDIOCHIRURGII U PACIENTOV S MALÍGNYM MELANÓMOM UVEY.
Źródło :
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti [Cesk Slov Oftalmol] 2020 Winter; Vol. 76 (1), pp. 46-51.
Typ publikacji :
Journal Article
MeSH Terms :
Melanoma*/radiotherapy
Melanoma*/surgery
Radiosurgery*
Uveal Neoplasms*/radiotherapy
Uveal Neoplasms*/surgery
Humans ; Retrospective Studies ; Slovakia ; Treatment Outcome
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients.
Autorzy :
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Rossi G; Pathology Unit, Azienda USL Romagna, St. Maria delle Croci Hospital, Ravenna, Italy.
Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Barberis M; Unit of Histopathology and Molecular Diagnostics, European Institute of Oncology IRCCS, Milano, Italy.
Buttitta F; Center for Advanced Studies and Technology (CAST) - Department of Medical, Oral and Biotechnological Sciences, University of Chieti, Italy.
Castiglione F; Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Cecere FL; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Grimaldi AM; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Iaccarino A; Department of Public Health, University of Naples Federico II, Naples, Italy.
Marchetti A; Center for Advanced Studies and Technology (CAST) - Department of Medical, Oral and Biotechnological Sciences, University of Chieti, Italy.
Massi D; Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Medicina D; Section of Pathology, Asst Spedali Civili di Brescia, Brescia, Italy.
Mele F; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Minari R; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Orlando E; Department of Health Promotion, Mother and Child care, Internal Medicine and Medical Specialties (ProMISE), Unit of Anatomic Pathology, University of Palermo, Palermo, Italy.
Pagni F; Department of Medicine and Surgery, Pathology, University Milan Bicocca, Milan, Italy.
Palmieri G; Unit of Cancer Genetics, Institute of Genetic and Biomedical Research (IRGB), National Research Council (CNR), Sassari, Italy.
Righi L; Department of Oncology, San Luigi Hospital, University of Turin, Turin, Italy.
Russo A; Medical Oncology Unit, A.O. Papardo, Messina, Italy.
Tommasi S; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Vermi W; Section of Pathology, Asst Spedali Civili di Brescia, Brescia, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Dec; Vol. 156, pp. 103118. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Melanoma*/diagnosis
Melanoma*/genetics
Biomarkers ; Humans ; Mutation ; Proto-Oncogene Proteins B-raf/genetics
Czasopismo naukowe
Tytuł :
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer.
Autorzy :
Borgognoni L; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Pescitelli L; Dermatology Unit, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Gerlini G; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Brandani P; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Gelli R; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Giannotti V; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Bellucci F; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy.
Sestini S; Department of Plastic and Reconstructive Surgery, Melanoma and Skin Cancer Unit, Regional Melanoma Referral Center, S.M. Annunziata Hospital, Florence, Italy .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Nov; Vol. 40 (11), pp. 6485-6492.
Typ publikacji :
Journal Article
MeSH Terms :
Electrochemotherapy*
Melanoma/*therapy
Neoplasms, Second Primary/*therapy
Skin Neoplasms/*therapy
Adult ; Bleomycin/administration & dosage ; Carcinoma, Merkel Cell ; Female ; Humans ; Italy/epidemiology ; Male ; Melanoma/pathology ; Middle Aged ; Neoplasms, Second Primary/pathology ; Remission Induction ; Skin Neoplasms/pathology ; Treatment Outcome
SCR Disease Name :
Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł :
Protoflavones in melanoma therapy: Prooxidant and pro-senescence effect of protoapigenone and its synthetic alkyl derivative in A375 cells.
Autorzy :
Csekes E; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology Slovak Academy of Sciences, Dubravska cesta 9, 841 04 Bratislava, Slovak Republic.
Vágvölgyi M; Institute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, 6720 Szeged, Hungary.
Hunyadi A; Institute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, 6720 Szeged, Hungary.
Račková L; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology Slovak Academy of Sciences, Dubravska cesta 9, 841 04 Bratislava, Slovak Republic. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2020 Nov 01; Vol. 260, pp. 118419. Date of Electronic Publication: 2020 Sep 12.
Typ publikacji :
Journal Article
MeSH Terms :
Cyclohexanones/*pharmacology
Flavones/*pharmacology
Melanoma/*drug therapy
Melanoma/*pathology
Antineoplastic Agents, Phytogenic/chemistry ; Antineoplastic Agents, Phytogenic/pharmacology ; Autophagy/drug effects ; Biomarkers/metabolism ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cellular Senescence/drug effects ; Cyclohexanones/chemistry ; Flavones/chemistry ; Humans ; Melanoma/metabolism ; Reactive Oxygen Species/metabolism ; Superoxide Dismutase/metabolism ; beta-Galactosidase/metabolism
Czasopismo naukowe
Tytuł :
Loss-of-function variants in FSIP1 identified by targeted sequencing are associated with one particular subtype of mucosal melanoma.
Autorzy :
Chen M; Institute of Dermatology and Department of Dermatology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China; School of Life Sciences, Anhui Medical University, Hefei, Anhui, China.
Wu Y; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China; School of Life Sciences, Anhui Medical University, Hefei, Anhui, China.
Li W; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China; School of Life Sciences, Anhui Medical University, Hefei, Anhui, China.
Zhang X; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China; Department of Pathology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Chen L; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China.
Zheng X; Institute of Dermatology and Department of Dermatology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Zuo X; Institute of Dermatology and Department of Dermatology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Zhou F; Institute of Dermatology and Department of Dermatology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Hong Y; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China.
Cheng H; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China.
Zhang M; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China.
Chen Z; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China.
Wu Q; Department of Pathology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Zhang X; Institute of Dermatology and Department of Dermatology the first Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China. Electronic address: .
Zhang B; Department of Oncology, No. 2 Hospital, Anhui Medical University, Hefei, Anhui, China; School of Life Sciences, Anhui Medical University, Hefei, Anhui, China. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2020 Oct 30; Vol. 759, pp. 144964. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Journal Article
MeSH Terms :
Loss of Function Mutation*
Carrier Proteins/*genetics
Melanoma/*genetics
Seminal Plasma Proteins/*genetics
Aged ; Female ; Humans ; Male ; Melanocytes/metabolism ; Melanocytes/pathology ; Melanoma/classification ; Melanoma/pathology ; Middle Aged ; Mucous Membrane/metabolism ; Mucous Membrane/pathology
Czasopismo naukowe
Tytuł :
Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
Autorzy :
Kashyap S; Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Singh MK; Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Jha J; Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Singh L; Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Pushker N; Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Sen S; Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Venkatesh P; Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Meel R; Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Lomi N; Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India. .
Pokaż więcej
Źródło :
Human cell [Hum Cell] 2020 Oct; Vol. 33 (4), pp. 1264-1272. Date of Electronic Publication: 2020 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*analysis
Guanine Nucleotide Exchange Factors/*analysis
Melanoma/*diagnosis
Membrane Transport Proteins/*analysis
Uveal Neoplasms/*diagnosis
Adult ; Disease-Free Survival ; Female ; Gene Expression ; Guanine Nucleotide Exchange Factors/genetics ; Humans ; Immunohistochemistry ; Male ; Melanoma/genetics ; Melanoma/mortality ; Melanoma/pathology ; Membrane Transport Proteins/genetics ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Uveal Neoplasms/genetics ; Uveal Neoplasms/mortality ; Uveal Neoplasms/pathology
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Intracellular accumulation of PD-1 molecules in circulating T lymphocytes in advanced malignant melanoma: an implication for immune evasion mechanism.
Autorzy :
Takahashi R; Flow Cytometry Core Facility, Kyorin University Graduate School of Medicine, Tokyo, Japan.
Sato Y; Department of Dermatology, Kyorin University Faculty of Medicine, 6-20-2 Shinkawa, Mitaka city, Tokyo, 181-8611, Japan.
Kimishima M; Department of Dermatology, Kyorin University Faculty of Medicine, 6-20-2 Shinkawa, Mitaka city, Tokyo, 181-8611, Japan.
Shiohara T; Flow Cytometry Core Facility, Kyorin University Graduate School of Medicine, Tokyo, Japan.; Department of Dermatology, Kyorin University Faculty of Medicine, 6-20-2 Shinkawa, Mitaka city, Tokyo, 181-8611, Japan.
Ohyama M; Flow Cytometry Core Facility, Kyorin University Graduate School of Medicine, Tokyo, Japan. .; Department of Dermatology, Kyorin University Faculty of Medicine, 6-20-2 Shinkawa, Mitaka city, Tokyo, 181-8611, Japan. .
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Oct; Vol. 25 (10), pp. 1861-1869. Date of Electronic Publication: 2020 Jul 12.
Typ publikacji :
Journal Article
MeSH Terms :
Melanoma/*immunology
Nivolumab/*pharmacology
Programmed Cell Death 1 Receptor/*metabolism
T-Lymphocytes/*metabolism
Tumor Escape/*immunology
Antineoplastic Agents, Immunological/pharmacology ; Biomarkers, Tumor/immunology ; Biomarkers, Tumor/metabolism ; Humans ; Immunotherapy/adverse effects ; Melanoma/drug therapy ; Melanoma/metabolism ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; Tumor Escape/drug effects
Czasopismo naukowe
Tytuł :
Combined microscope and endoscopy total resection of primary pineal malignant melanoma: case report and literature review.
Autorzy :
Zhang J; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuhan, 430071, China.; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, 55905, USA.
Xiong Z; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuhan, 430071, China.
Chen J; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuhan, 430071, China. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Oct; Vol. 146 (10), pp. 2589-2594. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Brain Neoplasms/*pathology
Brain Neoplasms/*surgery
Melanoma/*pathology
Melanoma/*surgery
Pineal Gland/*pathology
Pineal Gland/*surgery
Aged ; Brain Neoplasms/diagnostic imaging ; Endoscopy/methods ; Humans ; Magnetic Resonance Imaging ; Male ; Melanoma/diagnostic imaging ; Pineal Gland/diagnostic imaging
Czasopismo naukowe
Tytuł :
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Autorzy :
Rouanet J; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France. .; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France. .; Centre Jean Perrin, 58, rue Montalembert, 63011, Clermont-Ferrand, France. .
Benboubker V; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Histocompatibility and Immunogenetics, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Akil H; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Hennino A; UMR INSERM 1052 CNRS 5286 CRCL, 28 rue Laennec, 69008, Lyon, France.
Auzeloux P; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Besse S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Pereira B; Biostatistics Unit, DRCI, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Delorme S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Mansard S; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France.
D'Incan M; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France.
Degoul F; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
Rouzaire PO; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.; Department of Histocompatibility and Immunogenetics, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Oct; Vol. 69 (10), pp. 2075-2088. Date of Electronic Publication: 2020 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Immunotherapy/*methods
Iodine Radioisotopes/*therapeutic use
Melanoma, Experimental/*immunology
Melanoma, Experimental/*therapy
Radiation Tolerance/*drug effects
Animals ; Combined Modality Therapy ; Melanoma, Experimental/pathology ; Mice ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
Autorzy :
Kim MS; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Hong HK; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Ko YJ; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Park KH; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Ueno S; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Okado S; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Woo SJ; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.
Joo K; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea. .
Pokaż więcej
Źródło :
Documenta ophthalmologica. Advances in ophthalmology [Doc Ophthalmol] 2020 Dec; Vol. 141 (3), pp. 313-318. Date of Electronic Publication: 2020 May 29.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Melanoma/*immunology
Paraneoplastic Syndromes, Ocular/*immunology
Retina/*physiopathology
Skin Neoplasms/*immunology
TRPM Cation Channels/*immunology
Vision Disorders/*physiopathology
Blotting, Western ; Electroretinography ; Fluorescein Angiography ; Humans ; Male ; Melanoma/pathology ; Middle Aged ; Paraneoplastic Syndromes, Ocular/pathology ; Skin Neoplasms/pathology ; Tomography, Optical Coherence ; Visual Acuity/physiology ; Visual Field Tests ; Visual Fields/physiology
SCR Disease Name :
Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł :
Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis.
Autorzy :
Parker T; Nuffield Department of Surgery, University of Oxford, Oxford, UK. Electronic address: .
Rigney G; Department of Psychiatry, University of Oxford, Oxford, UK.
Kallos J; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Stefko ST; Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Kano H; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Niranjan A; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Green AL; Nuffield Department of Surgery, University of Oxford, Oxford, UK.
Aziz T; Nuffield Department of Surgery, University of Oxford, Oxford, UK.
Rath P; Everett and Hurite Ophthalmic Association, Pittsburgh, PA, USA.
Lunsford LD; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1526-1536.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Melanoma/*surgery
Neoplasm Recurrence, Local/*surgery
Radiosurgery/*methods
Uveal Neoplasms/*surgery
Humans ; Melanoma/pathology ; Melanoma/radiotherapy ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Radiosurgery/adverse effects ; Treatment Outcome ; Uveal Neoplasms/pathology ; Uveal Neoplasms/radiotherapy
SCR Disease Name :
Uveal melanoma
Czasopismo naukowe
Tytuł :
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Autorzy :
Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: .
Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mandalá M; Papa Giovanni XIII Hospital, Bergamo, Italy.
Gogas H; National and Kapodistrian University of Athens, Athens, Greece.
Arance AM; Hospital Clínic de Barcelona-IDIBAPS, Barcelona, Spain.
Dalle S; Hospices Civils de Lyon, Pierre Bénite, France.
Cowey CL; Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas, TX, USA.
Schenker M; Oncology Center Sf Nectarie, Craiova, Romania.
Grob JJ; Department of Dermatology, Aix-Marseille University, Hôpital de la Timone, Marseille, France.
Chiarion-Sileni V; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Márquez-Rodas I; Department of Medical Oncology, General University Hospital Gregorio Marañón and CIBERONC, Madrid, Spain.
Butler MO; Department of Immuno-oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Maio M; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
Middleton MR; Department of Oncology, Churchill Hospital, Oxford, UK.
de la Cruz-Merino L; Department of Clinical Oncology, Hospital University Virgen Macarena, Seville, Spain.
Arenberger P; Department of Dermatology, Charles University Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Atkinson V; Division of Cancer Services, Gallipoli Medical Research Foundation, University of Queensland, Brisbane, QLD, Australia.
Hill A; Department of Medical Oncology, Tasman Health Care, Southport, QLD, Australia.
Fecher LA; Department of Medical Oncology, Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
Millward M; Department of Internal Medicine, University of Western Australia and Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Khushalani NI; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center, Tampa, FL, USA.
Queirolo P; IEO European Institute of Oncology IRCCS, Milan, Italy.
Lobo M; Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA.
de Pril V; Department of Global Regulatory and Safety Sciences, Bristol Myers Squibb, Princeton, NJ, USA.
Loffredo J; Clinical Biomarkers, Bristol Myers Squibb, Princeton, NJ, USA.
Larkin J; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Weber J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1465-1477. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug-Related Side Effects and Adverse Reactions/*pathology
Ipilimumab/*administration & dosage
Melanoma/*drug therapy
Nivolumab/*administration & dosage
Aged ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/genetics ; Disease-Free Survival ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/classification ; Female ; Humans ; Ipilimumab/adverse effects ; Male ; Melanoma/genetics ; Melanoma/pathology ; Melanoma/surgery ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Neoplasm Staging ; Nivolumab/adverse effects ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies